Castanospermine

Drug Profile

Castanospermine

Alternative Names: CAST; CST; MDL 26190

Latest Information Update: 20 Feb 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Anutech
  • Developer Anutech; Nonindustrial source
  • Class Antihyperglycaemics; Antivirals; Indolizines; Small molecules
  • Mechanism of Action Alpha-glucosidase inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diabetes mellitus; Transplant rejection

Most Recent Events

  • 20 Feb 2007 Discontinued - Preclinical for Transplant rejection in Australia (unspecified route)
  • 26 Jul 2001 No-Development-Reported for Transplant rejection in Australia (Unknown route)
  • 21 Aug 1997 Data have been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top